AMI Japan

AMI Inc. is a medical technology startup established in November 2015 by Dr. Shimpei Ogawa, a practicing cardiologist. The company was founded on Dr. Ogawa's vision to detect heart disease before symptoms appear, leading him to develop a prototype medical device that became the foundation of the company. AMI is dedicated to the mission of "realizing rapid medical innovation" and is focused on transforming cardiac auscultation, a field that has seen little change in 200 years.

The company's core product is the "AMI-SSS01 Series Phonocardiograph," also known as the "Super Stethoscope". This device simultaneously records both phonocardiogram (heart sounds) and electrocardiogram (ECG) data. It is designed to capture low-frequency heart sounds down to 20 Hz with high accuracy, addressing a key limitation of traditional stethoscopes. By combining these two physiological signals with proprietary AI and deep learning models, AMI aims to provide deeper insights into cardiac function and assist in the early diagnosis of conditions like heart valve disease and heart failure.

AMI operates on a business model that includes the sale of its hardware and the development of Software as a Medical Device (SaMD). The company also offers a telemedicine platform, Cloud ChouShin®, which allows for the remote sharing of heart sounds, ECG signals, and analysis results, facilitating doctor-to-doctor consultations and expanding access to advanced cardiac diagnostics. This enables a decentralized model of care where various healthcare personnel can perform cardiac assessments under a physician's supervision. The company targets challenges in clinical practice, medical research, and telemedicine. AMI has raised significant funding, including a ¥910 million Series B round, to accelerate sales, recruit engineers and business development teams, and pursue overseas expansion, particularly in North America and Asia.

Keywords: cardiovascular diagnostics, phonocardiograph, electrocardiogram, medical device, digital health, telemedicine, AI diagnostics, heart disease screening, auscultation, SaMD, Super Stethoscope, cardiac assessment, remote auscultation, heart sound analysis, deep learning, clinical decision support, medical innovation, ECG, heart failure detection, valvular heart disease